Anlotinib Plus Chemotherapy for Patients With Advanced Non-small Cell Lung Cancer

Conditions:   Lung Neoplasms;   Docetaxel;   Pemetrexed;   S-1;   Anlotinib Interventions:   Drug: anlotinib plus chemotherapy;   Drug: chemotherapy Sponsors:   The First People's Hospital of Lianyungang;   Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Not yet recruiting

Source: ClinicalTrials.gov - July 18, 2018 Category: Research Source Type: clinical trials